Specific allergen immunotherapy vs no immunotherapy
Participant‐ or parent‐reported global assessment of disease severity · adults and children with atopic eczema and inhalant allergen sensitisation
1 finding from 1 review
- Specific allergen immunotherapy for the treatment of atopic eczema 2016 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 44 participantsLow